文献速递主动脉疾病

腹主动脉瘤腔内修复术中瘤囊弹簧圈栓塞的前瞻性随机两中心试验

Prospective, Randomised Two Centre Trial of Endovascular Repair of Abdominal Aortic Aneurysm With or Without Sac Embolisation.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2020-12-17

结果显示栓塞组在 1、6、12 个月的内漏发生率显著低于标准组,但 24 个月时差异无统计学意义;栓塞组再干预率更低,瘤囊体积缩小更快。

要点

  • 高 II 型内漏风险患者行 EVAR 时联合瘤囊弹簧圈栓塞可显著降低早期内漏发生率。
  • 栓塞组 24 个月时内漏发生率与标准组差异无统计学意义。
  • 栓塞组再干预率更低且瘤囊体积缩小更快。

核心结论

  • 对于有内漏风险的选择性患者,瘤囊弹簧圈栓塞似乎能在 1、6、12 个月有效预防内漏,但 24 个月时差异无统计学意义。
  • 瘤囊弹簧圈栓塞降低了 EVAR 后两年的再干预率,并观察到术后 1 年和 2 年瘤囊体积缩小显著更快。

研究设计与样本

  • 前瞻性随机两中心试验(SCOPE 1),纳入 2014–2019 年高 II 型内漏风险的腹主动脉瘤患者。
  • 主要终点为随访期间所有类型内漏的发生率;次要终点包括免于 II 型内漏相关再干预、两年随访时瘤囊直径和体积变化。

主要发现

  • 1 个月时 A 组 16/47(34%)发生早期 II 型内漏,B 组 2/47(4.3%)发生(p < .001)。
  • 6 个月时 A 组 15/36(41.7%)发生 II 型内漏,B 组 2/39(4.26%)发生(p < .001)。
  • 12 个月时 A 组 15/37(40.5%)发生 II 型内漏,B 组 5/35(14.3%)发生(p = .018)。
  • 24 个月时 A 组 8/32(25%)发生 II 型内漏,B 组 3/29(6.5%)发生(p = .19)。
  • 免于内漏和再干预的 Kaplan-Meier 曲线显著有利于 B 组(p < .001);瘤囊体积在 6 个月(p = .081)、12 个月(p = .004)和 24 个月(p = .001)时 B 组较 A 组显著减小。

临床怎么用

  • 对于高 II 型内漏风险的腹主动脉瘤患者,EVAR 术中联合瘤囊弹簧圈栓塞可考虑用于减少早期内漏和再干预。
  • 术后应规律进行 CTA 和双功超声随访以监测内漏和瘤囊体积变化。

局限性

  • 研究仅纳入高 II 型内漏风险的选择性患者,结论外推需谨慎。
  • 24 个月时内漏发生率差异无统计学意义,远期获益尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The benefit of aneurysm sac coil embolisation (ASCE) during endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA) remains unclear. This prospective randomised two centre study (SCOPE 1: Sac COil embolisation for Prevention of Endoleak) compared the outcomes of standard EVAR in patients with AAA at high risk of type II endoleak (EL with EVAR with ASCE during the period 2014-2019. METHODS: Patients at high risk of type II EL were randomised to standard EVAR (group A) or EVAR with coil ASCE (group B). The primary endpoint was the rate of all types of EL during follow up. Secondary endpoints included freedom from type II EL related re-interventions, and aneurysm sac diameter and volume variation at two year follow up. Adverse events included type II EL and re-interventions. CTA and Duplex ultrasound scans were scheduled at 30 days, six months, one year, and two years after surgery. RESULTS: Ninety-four patients were enrolled, 47 in each group. There were no intra-operative complications. At M1, 16/47 early type II EL occurred (34%) in group A vs. 2/47 (4.3%) in group B (p < .001). At M6, 15/36 type II EL (41.7%) occurred in group A vs. 2/39 (4.26%) in group B (p < .001). At M12, 15/37 type II El (40.5%) occurred in group A vs. 5/35 (14.3%) in group B (p = .018). At 24 months, 8/32 type 2 El (25%) occurred in group A vs. 3/29 (6.5%) in group B (p = .19). Kaplan-Meier curves of survival free from EL and re-interventions were significantly in favour of group B (p < .001). Aneurysm sac volume decreased significantly in group B compared with group A at M6 (p = .081), at M12 (p = .004), and M24 (p = .001). CONCLUSION: For selected patients at risk of EL, ASCE seems effective in preventing EL at one, six, and at 12 months. However, the difference was not statistically significant at 24 months. ASCE decreases the re-intervention rate two years after EVAR. A significantly faster aneurysm volume shrinkage was observed at one and two years following surgery. (SCOPE 1 trial: NCT01878240).

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Fabre D, Mougin J, Mitilian D, et al. Prospective, Randomised Two Centre Trial of Endovascular Repair of Abdominal Aortic Aneurysm With or Without Sac Embolisation. Eur J Vasc Endovasc Surg. 2020. PMID: 33342658. doi:10.1016/j.ejvs.2020.11.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。